Skip to content

Clinical trials

Phase 1/2 Lymphoma, B-Cell, Marginal Zone trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 1/2 Country / region: Italy Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20141
20181
20192
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Acerta Pharma BV1
BeOne Medicines1
Enterome1
Genmab1
IGM Biosciences, Inc.1
Loxo Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone8
Lymphoma, Follicular7
Lymphoma, Non-Hodgkin6
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Mantle-Cell5
Waldenstrom Macroglobulinemia4
Dendritic Cell Sarcoma, Interdigitating3
Lymphoma, Large B-Cell, Diffuse3
Recurrence3
Burkitt Lymphoma2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.